MFF Gene Mitochondrial Encephalomyopathy Genetic Test
Cost: AED 4400.0
Symptoms and Diagnosis
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a rare genetic disorder that affects the energy-producing mitochondria in the body. It is caused by mutations in the mitochondrial DNA (mtDNA) and is typically inherited maternally.
Test Details
The MFF gene is one of the genes that can be analyzed using Next-generation sequencing (NGS) for MELAS genetic testing. Mutations in the MFF gene have been found to be associated with a subtype of MELAS characterized by myopathy and optic atrophy.
The NGS genetic test for MELAS typically involves obtaining a blood or tissue sample from the individual suspected of having the condition. The DNA from the sample is then extracted and sequenced using NGS technology. The sequencing data is analyzed to identify any mutations or variations in the mitochondrial genes, including the MFF gene, that may be responsible for causing MELAS.
The results of the NGS genetic test can help confirm a diagnosis of MELAS and provide information about the specific genetic mutation(s) present. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options for individuals with MELAS.
Test Components and Price
- Test Name: MFF Gene Mitochondrial encephalomyopathy Genetic Test
- Components: NGS Technology
- Price: AED 4400.0
Sample Condition and Report Delivery
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Test Type and Doctor
- Test Type: Neurological Disorders
- Doctor: Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for MFF Gene Mitochondrial encephalomyopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MFF Gene Mitochondrial encephalomyopathy.
| Test Name | MFF Gene Mitochondrial encephalomyopathy Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MFF Gene Mitochondrial encephalomyopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MFF Gene Mitochondrial encephalomyopathy |
| Test Details |
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a rare genetic disorder that affects the energy-producing mitochondria in the body. It is caused by mutations in the mitochondrial DNA (mtDNA) and is typically inherited maternally. Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or the entire genome. In the context of MELAS, NGS can be used to perform a genetic test to identify mutations in the mitochondrial genes associated with the condition. The MFF gene is one of the genes that can be analyzed using NGS for MELAS genetic testing. Mutations in the MFF gene have been found to be associated with a subtype of MELAS characterized by myopathy and optic atrophy. The NGS genetic test for MELAS typically involves obtaining a blood or tissue sample from the individual suspected of having the condition. The DNA from the sample is then extracted and sequenced using NGS technology. The sequencing data is analyzed to identify any mutations or variations in the mitochondrial genes, including the MFF gene, that may be responsible for causing MELAS. The results of the NGS genetic test can help confirm a diagnosis of MELAS and provide information about the specific genetic mutation(s) present. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options for individuals with MELAS. |
